Annual Accounts Payable
$2.67 M
+$2.31 M+651.27%
December 31, 2023
Summary
- As of February 7, 2025, SMMT annual accounts payable is $2.67 million, with the most recent change of +$2.31 million (+651.27%) on December 31, 2023.
- During the last 3 years, SMMT annual accounts payable has fallen by -$3.47 million (-56.56%).
- SMMT annual accounts payable is now -78.65% below its all-time high of $12.49 million, reached on January 31, 2018.
Performance
SMMT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$3.25 M
-$88.00 K-2.63%
September 30, 2024
Summary
- As of February 7, 2025, SMMT quarterly accounts payable is $3.25 million, with the most recent change of -$88.00 thousand (-2.63%) on September 30, 2024.
- Over the past year, SMMT quarterly accounts payable has dropped by -$88.00 thousand (-2.63%).
- SMMT quarterly accounts payable is now -80.16% below its all-time high of $16.39 million, reached on April 30, 2018.
Performance
SMMT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
SMMT Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +651.3% | -2.6% |
| 3 y3 years | -56.6% | +816.1% |
| 5 y5 years | -54.0% | -65.1% |
SMMT Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -39.0% | +651.3% | -53.3% | +816.1% |
| 5 y | 5-year | -56.6% | +651.3% | -74.1% | +816.1% |
| alltime | all time | -78.7% | +7767.3% | -80.2% | +9492.9% |
Summit Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.25 M(-2.6%) |
| Jun 2024 | - | $3.34 M(-47.6%) |
| Mar 2024 | - | $6.37 M(+138.9%) |
| Dec 2023 | $2.67 M(+651.3%) | $2.67 M(-19.5%) |
| Sep 2023 | - | $3.31 M(+235.8%) |
| Jun 2023 | - | $987.00 K(+39.0%) |
| Mar 2023 | - | $710.00 K(+100.0%) |
| Dec 2022 | $355.00 K(-91.9%) | $355.00 K(-75.2%) |
| Sep 2022 | - | $1.43 M(-60.0%) |
| Jun 2022 | - | $3.57 M(-48.6%) |
| Mar 2022 | - | $6.96 M(+59.1%) |
| Dec 2021 | $4.37 M(-28.8%) | $4.37 M(-25.5%) |
| Sep 2021 | - | $5.88 M(-15.5%) |
| Jun 2021 | - | $6.95 M(+68.9%) |
| Mar 2021 | - | $4.11 M(-33.0%) |
| Dec 2020 | $6.14 M(+37.3%) | - |
| Dec 2020 | - | $6.14 M(+146.3%) |
| Sep 2020 | - | $2.49 M(-80.2%) |
| Mar 2020 | - | $12.56 M(+34.9%) |
| Dec 2019 | $4.47 M(-22.9%) | - |
| Oct 2019 | - | $9.31 M(+17.9%) |
| Jul 2019 | - | $7.90 M(-9.6%) |
| Apr 2019 | - | $8.74 M(+50.7%) |
| Jan 2019 | $5.80 M(-53.6%) | - |
| Jan 2019 | - | $5.80 M(-14.1%) |
| Oct 2018 | - | $6.75 M(-22.0%) |
| Jul 2018 | - | $8.65 M(-47.2%) |
| Apr 2018 | - | $16.39 M(+31.2%) |
| Jan 2018 | $12.49 M(+1003.0%) | - |
| Jan 2018 | - | $12.49 M(+141.4%) |
| Oct 2017 | - | $5.17 M(+12.1%) |
| Jul 2017 | - | $4.61 M(+11.8%) |
| Apr 2017 | - | $4.13 M(+264.5%) |
| Jan 2017 | $1.13 M | - |
| Jan 2017 | - | $1.13 M(-70.6%) |
| Oct 2016 | - | $3.86 M(-11.9%) |
| Jul 2016 | - | $4.38 M(-4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2016 | - | $4.57 M(+348.3%) |
| Jan 2016 | $1.02 M(-81.0%) | - |
| Jan 2016 | - | $1.02 M(-76.4%) |
| Oct 2015 | - | $4.32 M(+3.9%) |
| Jul 2015 | - | $4.15 M(-0.5%) |
| Apr 2015 | - | $4.18 M(-22.4%) |
| Jan 2015 | $5.38 M(+834.3%) | - |
| Jan 2015 | - | $5.38 M(+33.2%) |
| Oct 2014 | - | $4.04 M(-9.2%) |
| Jul 2014 | - | $4.45 M(+672.4%) |
| Jan 2014 | $575.70 K(+43.5%) | - |
| Jan 2014 | - | $575.70 K(-74.1%) |
| Jul 2013 | - | $2.22 M(+454.6%) |
| Jan 2013 | $401.20 K(-31.3%) | - |
| Jan 2013 | - | $401.20 K(-62.7%) |
| Jul 2012 | - | $1.08 M(+84.2%) |
| Jan 2012 | $584.20 K(+11.2%) | - |
| Jan 2012 | - | $584.20 K(-81.0%) |
| Jul 2011 | - | $3.08 M(+486.0%) |
| Jan 2011 | $525.40 K(+120.8%) | - |
| Jan 2011 | - | $525.40 K(-59.5%) |
| Jul 2010 | - | $1.30 M(+444.8%) |
| Jan 2010 | $238.00 K(-75.5%) | - |
| Jan 2010 | - | $238.00 K(-77.0%) |
| Jul 2009 | - | $1.03 M(+6.3%) |
| Jan 2009 | $972.90 K(-73.0%) | - |
| Jan 2009 | - | $972.90 K(-80.8%) |
| Jul 2008 | - | $5.08 M(+40.9%) |
| Jan 2008 | $3.61 M(+59.7%) | - |
| Jan 2008 | - | $3.61 M(-7.2%) |
| Jul 2007 | - | $3.89 M(+72.2%) |
| Jan 2007 | $2.26 M(+159.2%) | - |
| Jan 2007 | - | $2.26 M(+345.9%) |
| Jul 2006 | - | $506.30 K(-41.9%) |
| Jan 2006 | $871.10 K(+2469.6%) | - |
| Jan 2006 | - | $871.10 K(+2469.6%) |
| Jan 2005 | $33.90 K | - |
| Jan 2005 | - | $33.90 K |
FAQ
- What is Summit Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Summit Therapeutics?
- What is Summit Therapeutics annual accounts payable year-on-year change?
- What is Summit Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Summit Therapeutics?
- What is Summit Therapeutics quarterly accounts payable year-on-year change?
What is Summit Therapeutics annual accounts payable?
The current annual accounts payable of SMMT is $2.67 M
What is the all time high annual accounts payable for Summit Therapeutics?
Summit Therapeutics all-time high annual accounts payable is $12.49 M
What is Summit Therapeutics annual accounts payable year-on-year change?
Over the past year, SMMT annual accounts payable has changed by +$2.31 M (+651.27%)
What is Summit Therapeutics quarterly accounts payable?
The current quarterly accounts payable of SMMT is $3.25 M
What is the all time high quarterly accounts payable for Summit Therapeutics?
Summit Therapeutics all-time high quarterly accounts payable is $16.39 M
What is Summit Therapeutics quarterly accounts payable year-on-year change?
Over the past year, SMMT quarterly accounts payable has changed by -$88.00 K (-2.63%)